Optical biomarkers of serous and mucinous human ovarian tumor assessed with nonlinear optics microscopies.
The MRI findings in a case of ovarian mucinous borderline tumor mimicking a serous surface borderline tumor.
Comparison of tumor markers and clinicopathological features in serous and mucinous borderline ovarian tumors.
Management of borderline ovarian tumours.
Gershenson DM.
Best Pract Res Clin Obstet Gynaecol. 2017 May;41:49-59. doi: 10.1016/j.bpobgyn.2016.09.012. Epub 2016 Oct 3.
Serous tubal intraepithelial carcinoma (STIC) - clinical impact and management.
Weinberger V, Bednarikova M, Cibula D, Zikan M.
Expert Rev Anticancer Ther. 2016 Dec;16(12):1311-1321. doi: 10.1080/14737140.2016.1247699. Epub 2016 Oct 22.
Serous and mucinous borderline ovarian tumours: differences in clinical presentation, high-risk histopathological features, and lethal recurrence rates.
Vasconcelos I, Darb-Esfahani S, Sehouli J.
BJOG. 2016 Mar;123(4):498-508. doi: 10.1111/1471-0528.13840. Epub 2015 Dec 25.
Giant Mucinous Borderline Ovarian Tumor Presenting Alongside Perforated Peptic Ulcers.
Pence S, Christiansen A, George E.
J Obstet Gynaecol Can. 2024 Mar;46(3):102114. doi: 10.1016/j.jogc.2023.04.005. Epub 2023 Apr 13.
International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas.
Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M, Yamaguchi K, Yamao K, Matsuno S; International Association of Pancreatology.
Pancreatology. 2006;6(1-2):17-32. doi: 10.1159/000090023.
Ovarian Mucinous Borderline Tumor With Intraepithelial Carcinoma.
Chiesa-Vottero AG.
Int J Gynecol Pathol. 2023 Sep 1;42(5):514. doi: 10.1097/PGP.0000000000000912. Epub 2022 Aug 31.
A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas.
Basturk O, Hong SM, Wood LD, Adsay NV, Albores-Saavedra J, Biankin AV, Brosens LA, Fukushima N, Goggins M, Hruban RH, Kato Y, Klimstra DS, Klöppel G, Krasinskas A, Longnecker DS, Matthaei H, Offerhaus GJ, Shimizu M, Takaori K, Terris B, Yachida S, Esposito I, Furukawa T; Baltimore Consensus Meeting.
Am J Surg Pathol. 2015 Dec;39(12):1730-41. doi: 10.1097/PAS.0000000000000533.
Association between pelvic inflammatory disease, infertility, ectopic pregnancy and the development of ovarian serous borderline tumor, mucinous borderline tumor and low-grade serous carcinoma.
Stewart LM, Stewart CJR, Spilsbury K, Cohen PA, Jordan S.
Gynecol Oncol. 2020 Mar;156(3):611-615. doi: 10.1016/j.ygyno.2020.01.027. Epub 2020 Jan 23.
The Epithelial-Mesenchymal Transition, E-cadherin and Tumor Progression in Ovarian Serous Tumors.
Bozhkova DM, Poryazova-Markova EG.
Folia Med (Plovdiv). 2019 Jun 1;61(2):296-302. doi: 10.2478/folmed-2018-0082.
High-grade serous ovarian tumor cells modulate NK cell function to create an immune-tolerant microenvironment.
Gonzalez VD, Huang YW, Delgado-Gonzalez A, Chen SY, Donoso K, Sachs K, Gentles AJ, Allard GM, Kolahi KS, Howitt BE, Porpiglia E, Fantl WJ.
Cell Rep. 2021 Aug 31;36(9):109632. doi: 10.1016/j.celrep.2021.109632.
